Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855900) titled 'SYNCHRONIZE(R)-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight' on Sept. 29.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Boehringer Ingelheim
Condition:
Obesity
Intervention:
Combination Product: Survodutide
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: November 7, 2026
Target Sample Size: 350
Countries of Recruitment:
United States
To know more, visit htt...